PEMBROLIZUMAB PLUS CARBOPLATIN AND PACLITAXEL AS FIRST-LINE THERAPY FOR RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (KEYNOTE-B10): A SINGLE-ARM PHASE IV TRIAL. (17 Settembre 2024)

DURABILITY OF RESPONSE WITH SELPERCATINIB IN PATIENTS WITH RET-ACTIVATED THYROID CANCER: A LONG-TERM SAFETY AND EFFICACY FROM LIBRETTO-001. (10 Settembre 2024)

REGOMA-OSS: A LARGE, ITALIAN, MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY EVALUATING THE EFFICACY AND SAFETY OF REGORAFENIB IN PATIENTS WITH RECURRENT GLIOBASTOMA. (28 Maggio 2024)

PROPHYLACTIC RADIATION THERAPHY VERSUS STANDARD OF CARE FOR PATIENTS WITH HIGH-RISK ASYMPTOMATIC BONE METASTASIS: A MULTICENTER, RANDOMIZED PHASE II CLINICAL TRIAL. (05 Febbraio 2024)

RELATIVE BURDEN OF CANCER AND NONCANCER MORTALITY AMONG LONG-TERM SURVIVORS OF BREAST, PROSTATE, AND COLORECTAL CANCER IN THE US. (28 Novembre 2024)

RELATIVE BURDEN OF CANCER AND NONCANCER MORTALITY AMONG LONG-TERM SURVIVORS OF BREAST, PROSTATE, AND COLORECTAL CANCER IN THE US. (Novembre  2023)

INTRA-INDIVIDUAL COMPARISON  ¹⁸F-SODIUM FLUORIDE PET–CT AND  ⁹⁹mTc BONE SCINTIGRAPHY WITH SPECT IN PATIENTS WITH PROSTATE CANCER OR BREAST CANCER AT HIGH RISK FOR SKELETAL METASTASES (MITNEC-A1): A MULTICENTRE, PHASE 3 TRIAL. (Febbraio 2023)

BLOOD PRESSURE CLASSIFICATION USING THE 2017 ACC/AHA GUIDELINE AND HEART FAILURE IN PATIENTS WITH CANCER (Febbraio 2023)